Thomas F. D.
- Country
- Denmark
- Department
- Department of Endocrinology and Nephrology
Research Overview
- Phase III Randomized, Double‑Blind, Parallel‑Group Study of Elecoglipron Added to Dapagliflozin in Adults with Type 2 Diabetes Mellitus and Impaired Renal Function
- Phase III Randomized Double‑Blind Study of Elecoglipron Plus Dapagliflozin Versus Elecoglipron or Dapagliflozin Monotherapy in Adults with Type 2 Diabetes Mellitus
- Screening and intervention for subclinical coronary artery disease in patients with type 2 diabetes: THE STENO INTEN-CT STUDY
Data & Insights
Has run more than one trial at 12 of 105 partner sites.
Specializations
Diabetes Management
This investigator specializes in comprehensive research addressing both Type 1 and Type 2 diabetes, with particular emphasis on developing innovative treatment approaches and preventive strategies.
- Cardiovascular complications in Type 1 diabetes
- Intensive care strategies for diabetic patients
- Subclinical coronary artery disease screening
The research focus includes developing targeted interventions for high-risk diabetic populations and evaluating cardiac screening protocols.
Cardiovascular Health
The investigator conducts extensive research in cardiovascular disease prevention and management, particularly in diabetic populations.
- Heart failure risk assessment
- Coronary artery disease detection
- Cardiovascular screening protocols
Their work encompasses innovative screening methodologies using cardiac imaging and preventive interventions.
Metabolic Disorders
Research efforts extend to treating complex metabolic conditions, with a focus on the intersection of diabetes and obesity.
- Weight management in diabetes
- Novel therapeutic approaches
- Lifestyle intervention strategies
The investigator explores integrated treatment approaches combining medical interventions with lifestyle modifications.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.